These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3054372)

  • 1. In vitro effectiveness of 13 agents in otomycosis and review of the literature.
    Stern JC; Shah MK; Lucente FE
    Laryngoscope; 1988 Nov; 98(11):1173-7. PubMed ID: 3054372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug therapy in otomycosis: an in vitro study.
    Lawrence TL; Ayers LW; Saunders WH
    Laryngoscope; 1978 Nov; 88(11):1755-60. PubMed ID: 713671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototopical antifungals and otomycosis: a review.
    Munguia R; Daniel SJ
    Int J Pediatr Otorhinolaryngol; 2008 Apr; 72(4):453-9. PubMed ID: 18279975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of fungal infections of upper respiratory tract and ear].
    Kurnatowski P; Kurnatowska AK
    Otolaryngol Pol; 2007; 61(3):280-5. PubMed ID: 17847781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis.
    Karaarslan A; Arikan S; Ozcan M; Ozcan KM
    Mycoses; 2004 Aug; 47(7):284-7. PubMed ID: 15310330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad spectrum antifungal agents in otomycosis.
    Bassiouny A; Kamel T; Moawad MK; Hindawy DS
    J Laryngol Otol; 1986 Aug; 100(8):867-73. PubMed ID: 3746101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Otomycosis: Diagnosis and treatment.
    Vennewald I; Klemm E
    Clin Dermatol; 2010 Mar; 28(2):202-11. PubMed ID: 20347664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otomycosis: clinical and mycological study of 97 cases.
    Araiza J; Canseco P; Bonifaz A
    Rev Laryngol Otol Rhinol (Bord); 2006; 127(4):251-4. PubMed ID: 17315791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of sulfadrugs against fungi causing otomycosis.
    Jain SK; Agrawal SC; Jain PC
    Hindustan Antibiot Bull; 2002; 44(1-4):42-6. PubMed ID: 15061593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microbiological study of otomycosis in Visakhapatnam.
    Anwarullah M; Jayakar PA
    J Indian Med Assoc; 1987 Aug; 85(8):229-32. PubMed ID: 3429879
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antimycotic therapy in otomycosis with tympanic membrane perforation].
    Dyckhoff G; Hoppe-Tichy T; Kappe R; Dietz A
    HNO; 2000 Jan; 48(1):18-21. PubMed ID: 10663044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal agents: recent developments.
    Kobayashi GS; Medoff G
    Annu Rev Microbiol; 1977; 31():291-308. PubMed ID: 334040
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species.
    Thompson GR; Wiederhold NP; Sutton DA; Fothergill A; Patterson TF
    J Antimicrob Chemother; 2009 Jul; 64(1):79-83. PubMed ID: 19406849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Otomycosis in Turkey: predisposing factors, aetiology and therapy.
    Ozcan KM; Ozcan M; Karaarslan A; Karaarslan F
    J Laryngol Otol; 2003 Jan; 117(1):39-42. PubMed ID: 12590854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
    Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B
    Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of antimycotic preparations and natural proteinase inhibitors in otomycosis].
    Soushko YA; Borissenko ON; Volosevitch LI
    Rev Laryngol Otol Rhinol (Bord); 1993; 114(1):59-61. PubMed ID: 7514804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Otomycosis: an experimental evaluation of six antimycotic agents.
    Maher A; Bassiouny A; Moawad MK; Hendawy DS
    J Laryngol Otol; 1982 Mar; 96(3):205-13. PubMed ID: 6461705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of topical clotrimazole vs. topical tolnaftate in the treatment of otomycosis. A randomized controlled clinical trial.
    Jimenez-Garcia L; Celis-Aguilar E; Díaz-Pavón G; Muñoz Estrada V; Castro-Urquizo Á; Hernández-Castillo N; Amaro-Flores E
    Braz J Otorhinolaryngol; 2020; 86(3):300-307. PubMed ID: 30826311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
    Marangon FB; Miller D; Giaconi JA; Alfonso EC
    Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for fungal infections.
    Yoshikawa TT
    Am Fam Physician; 1980 Oct; 22(4):145-50. PubMed ID: 6893517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.